It has been suggested that TFPI-2 induces invasion of HCC through binding to tissue factor-factor/VIIa complex, since the specific anti-fVII antibody abolished TFPI-2 induced invasion of HCC cells [66]. Here, TFPI2 is linked to hepatocellular carcinoma.